Congenital Central Hypoventilation Syndrome

Introduction to Congenital Central Hypoventilation Syndrome (CCHS)

Congenital Central Hypoventilation Syndrome (CCHS), also known as Ondine's curse, is a rare genetic disorder characterized by autonomic nervous system dysfunction, particularly affecting respiratory control. CCHS primarily impacts the automatic control of breathing, especially during sleep, leading to hypoventilation and potential life-threatening complications if left untreated.

Etiology of CCHS

  • Genetic Basis: CCHS is caused by mutations in the PHOX2B gene, located on chromosome 4p12.
  • Inheritance Pattern: Typically autosomal dominant, with most cases resulting from de novo mutations.
  • Pathophysiology: The PHOX2B gene plays a crucial role in the development of the autonomic nervous system, including respiratory control centers in the brainstem.
  • Genotype-Phenotype Correlation: The severity and associated features of CCHS often correlate with the specific PHOX2B mutation type and size.

Clinical Presentation of CCHS

  • Respiratory Symptoms:
    • Hypoventilation, particularly during sleep
    • Absence of appropriate respiratory response to hypercapnia and hypoxemia
    • Apnea episodes
    • Cyanosis
  • Associated Features:
    • Hirschsprung's disease (in 15-20% of cases)
    • Neural crest tumors (e.g., neuroblastoma)
    • Cardiovascular abnormalities (e.g., cardiac arrhythmias)
    • Ophthalmologic issues (e.g., pupillary abnormalities)
    • Neurocognitive impairment (variable severity)
  • Age of Onset: Typically presents in the neonatal period, but late-onset cases have been reported.

Diagnosis of CCHS

  1. Clinical Suspicion: Based on presenting symptoms, especially recurrent hypoventilation or apnea during sleep.
  2. Genetic Testing: Confirmation of PHOX2B gene mutations is the gold standard for diagnosis.
  3. Polysomnography: To assess the severity of hypoventilation and sleep-disordered breathing.
  4. Blood Gas Analysis: To evaluate the degree of hypercapnia and hypoxemia.
  5. Autonomic Function Tests: To assess the extent of autonomic nervous system dysfunction.
  6. Additional Investigations:
    • Chest X-ray and echocardiogram to evaluate cardiopulmonary status
    • MRI of the brain and brainstem to rule out other central causes of hypoventilation
    • Screening for associated conditions (e.g., Hirschsprung's disease, neural crest tumors)

Management of CCHS

  1. Respiratory Support:
    • Mechanical ventilation (invasive or non-invasive) during sleep and, if necessary, during wakefulness
    • Tracheostomy may be required in severe cases
    • Diaphragm pacing in selected patients
  2. Monitoring:
    • Continuous pulse oximetry and capnography
    • Regular polysomnography to assess ventilation adequacy
  3. Management of Associated Conditions:
    • Surgical intervention for Hirschsprung's disease
    • Treatment of neural crest tumors
    • Cardiac management for arrhythmias
  4. Neurodevelopmental Support: Early intervention and ongoing assessment of cognitive and motor development.
  5. Family Education and Support: Training in home ventilation, emergency management, and genetic counseling.

Prognosis of CCHS

  • Life Expectancy: With appropriate management, many individuals with CCHS can have a near-normal life expectancy.
  • Quality of Life: Varies depending on the severity of symptoms and associated conditions.
  • Long-term Complications:
    • Neurocognitive impairment
    • Pulmonary hypertension
    • Cor pulmonale
    • Developmental delays
  • Ongoing Care: Lifelong respiratory support and multidisciplinary follow-up are essential.


Congenital Central Hypoventilation Syndrome
  1. What gene mutation is primarily associated with CCHS?
    PHOX2B gene mutation
  2. What is the primary respiratory characteristic of CCHS?
    Failure of automatic breathing control, especially during sleep
  3. What is another name for CCHS?
    Ondine's curse
  4. At what age are symptoms of CCHS typically first observed?
    Usually in newborns, but can appear later in childhood or adulthood
  5. What is the inheritance pattern of CCHS?
    Autosomal dominant
  6. What percentage of CCHS cases are due to de novo mutations?
    Approximately 90%
  7. What is the most common treatment for CCHS?
    Mechanical ventilation, often via tracheostomy
  8. What non-respiratory system is commonly affected in CCHS?
    Autonomic nervous system
  9. What gastrointestinal condition is associated with CCHS?
    Hirschsprung's disease
  10. What cardiac arrhythmia is associated with CCHS?
    Prolonged sinus pauses
  11. What ocular condition is commonly seen in CCHS patients?
    Pupillary abnormalities
  12. What neurological tumor is associated with CCHS?
    Neuroblastoma
  13. What is the typical blood gas finding in untreated CCHS?
    Hypercapnia (elevated CO2) with normal or near-normal O2 levels
  14. How is CCHS definitively diagnosed?
    Genetic testing for PHOX2B mutations
  15. What type of sleep study is used to assess CCHS severity?
    Polysomnography
  16. What is the role of caffeine in CCHS management?
    It is not effective in treating CCHS, unlike in premature infants
  17. What is the typical ventilatory response to hypercapnia in CCHS patients?
    Absent or blunted
  18. What is the risk of having a child with CCHS if one parent has the condition?
    50% chance with each pregnancy
  19. What is the most severe form of PHOX2B mutation in CCHS?
    Polyalanine repeat mutation (PARM) with 20/27 to 20/33 repeats
  20. What is Late Onset CCHS (LO-CCHS)?
    CCHS diagnosed after the neonatal period, often with milder symptoms
  21. What non-invasive ventilation method can be used in some CCHS patients?
    Bi-level positive airway pressure (BiPAP)
  22. What is diaphragm pacing in CCHS treatment?
    Electrical stimulation of the phrenic nerve to control diaphragm movement
  23. What hormone is often deficient in CCHS patients, affecting growth?
    Growth hormone
  24. What cognitive issues are common in CCHS patients?
    Learning disabilities and developmental delays
  25. What is the life expectancy for well-managed CCHS patients?
    Can be normal with appropriate lifelong ventilatory support
  26. What is the recommended frequency of follow-up for CCHS patients?
    At least annually, with more frequent visits in infancy and early childhood
  27. What precautions should CCHS patients take during anesthesia?
    Close monitoring and mechanical ventilation, as they may not breathe spontaneously
  28. What is the risk of respiratory arrest in CCHS patients during illness?
    Increased risk, requiring closer monitoring and potential ventilatory support
  29. What is the role of home monitoring in CCHS management?
    Essential for detecting hypoventilation and preventing complications
  30. What is the recommended approach for CCHS patients during pregnancy?
    Close monitoring and often increased ventilatory support


Further Reading


Powered by Blogger.